From: Updated clinical guidelines experience major reporting limitations
 | Overall scorea median (range) | p value |
---|---|---|
Institution | ||
Country | ||
− Europe | 8.1 (4.4–10.0) | 0.014 |
− International | 7.8 (6.9–8.8) | |
− Asia | 5.6 (3.8–6.3) | |
− North America | 5.6 (3.1–8.1) | |
Type of organisation | ||
− Public institution | 6.3 (3.1–10.0) | 0.617 |
− Scientific/professional society | 6.3 (3.1–8.8) | |
− Other (Federal institute, NGO) | 4.4 (3.8–8.1) | |
Updated clinical guidelines | ||
Scope | ||
− Diagnosis | 8.1 (5.0–9.4) | 0.097 |
− Prevention | 5.6 (4.4–6.3) | |
− Management | 6.3 (3.1–10.0) | |
− Treatment | 6.3 (4.4–8.8) | |
− Screening | 3.8 (3.1–8.1) | |
Health topic | ||
− Mental health | 6.9 (5.0–8.1) | 0.099 |
− Oncology | 6.3 (3.8–9.4) | |
− Internal medicine | 6.3 (5.6–8.1) | |
− Public health | 3.8 (3.1–3.8) | |
− Others | 6.3 (3.1–10.0) |